Torrent Pharmaceuticals Limited (BOM:500420)

Market Cap	1.54T +38.0%
Revenue (ttm)	139.80B +21.4%
Net Income	21.63B +13.2%
EPS	63.92 +13.2%
Shares Out	338.45M
PE Ratio	71.04
Forward PE	64.94
Dividend	38.00 (0.85%)
Ex-Dividend Date	May 29, 2026

Volume	6,604
Open	4,497.70
Previous Close	4,451.20
Day's Range	4,437.10 - 4,551.05
52-Week Range	3,103.00 - 4,714.50
Beta	0.14
Analysts	Buy
Price Target	4,870.59 (+7.26%)
Earnings Date	May 22, 2026

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It als...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 17,059
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500420

Financial Performance

In fiscal year 2026, Torrent Pharmaceuticals's revenue was 139.80 billion, an increase of 21.40% compared to the previous year's 115.16 billion. Earnings were 21.63 billion, an increase of 13.17%.